(Q45134905)

English

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists

scientific article published in October 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

fluticasone propionate

1 reference

based on heuristic

inferred from title

4

object named as

Kathryn Blake

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

John Murray

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard Rosenthal

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Laura Somerville

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Karen House

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Leslie Baitinger

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Anna VanderMeer

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Paul Dorinsky

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

93

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

351-359

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The complementary role of glucocorticosteroids and long-acting beta-adrenergic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961394-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)61394-4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45134905&oldid=2066730922"